Literature DB >> 12091354

ATM mutations are rare in familial chronic lymphocytic leukemia.

Martin R Yuille1, Alison Condie, Chantelle D Hudson, Paul S Bradshaw, Elaine M Stone, Estella Matutes, Daniel Catovsky, Richard S Houlston.   

Abstract

It is now recognized that a subset of B-cell chronic lymphocytic leukemia (CLL) is familial. The genetic basis of familial CLL is poorly understood, but recently germ line mutations in the Ataxia Telangiectasia (ATM) gene have been proposed to confer susceptibility to CLL. The evidence for this notion is, however, not unequivocal. To examine this proposition further we have screened the ATM gene for mutations in CLLs from 61 individuals in 29 families. Truncating ATM mutations, including a known ATM mutation, were detected in 2 affected individuals, but the mutations did not cosegregate with CLL in the families. In addition, 3 novel ATM missense mutations were detected. Common ATM missense mutations were not overrepresented. The data support previous observations that ATM mutation is associated with B-CLL. However, ATM mutations do not account for familial clustering of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091354     DOI: 10.1182/blood.v100.2.603

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.

Authors:  Gerard Lozanski; Amy S Ruppert; Nyla A Heerema; Arletta Lozanski; David M Lucas; Amber Gordon; John G Gribben; Vicki A Morrison; Kanti M Rai; Guido Marcucci; Richard A Larson; John C Byrd
Journal:  Leuk Lymphoma       Date:  2012-06-02

2.  A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci.

Authors:  Gabrielle S Sellick; Emily L Webb; Ruth Allinson; Estella Matutes; Martin J S Dyer; Viggo Jonsson; Anton W Langerak; Francesca R Mauro; Stephen Fuller; James Wiley; Matthew Lyttelton; Vincenzo Callea; Martin Yuille; Daniel Catovsky; Richard S Houlston
Journal:  Am J Hum Genet       Date:  2005-08-02       Impact factor: 11.025

3.  ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution.

Authors:  Romina Royo; Laura Magnano; Julio Delgado; Sara Ruiz-Gil; Josep Ll Gelpí; Holger Heyn; Malcom A Taylor; Tatjana Stankovic; Xose S Puente; Ferran Nadeu; Elías Campo
Journal:  Blood Cancer J       Date:  2022-06-07       Impact factor: 9.812

4.  DNA variants in the ATM gene are not associated with sporadic rectal cancer in a Norwegian population-based study.

Authors:  Annette Torgunrud Kristensen; Jens Bjørheim; Johan Wiig; Karl E Giercksky; Per O Ekstrøm
Journal:  Int J Colorectal Dis       Date:  2003-06-21       Impact factor: 2.571

Review 5.  Inherited predisposition to chronic lymphocytic leukemia.

Authors:  Jennifer R Brown
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

6.  Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.

Authors:  Peter Ouillette; Jinghui Li; Rita Shaknovich; Yifeng Li; Ari Melnick; Kerby Shedden; Sami N Malek
Journal:  Genes Chromosomes Cancer       Date:  2012-09-06       Impact factor: 5.006

7.  ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele.

Authors:  Anna Skowronska; Belinda Austen; Judith E Powell; Victoria Weston; David G Oscier; Martin J S Dyer; Estella Matutes; Guy Pratt; Christopher Fegan; Paul Moss; Malcolm A Taylor; Tatjana Stankovic
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

8.  Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders.

Authors:  Viggo Jønsson; Geir E Tjønnfjord; Tom B Johannesen; Sven Ove Samuelsen; Bernt Ly
Journal:  Transl Oncogenomics       Date:  2008-02-10

9.  The spectrum of ATM missense variants and their contribution to contralateral breast cancer.

Authors:  Annegien Broeks; Linde M Braaf; Angelina Huseinovic; Marjanka K Schmidt; Nicola S Russell; Flora E van Leeuwen; Frans B L Hogervorst; Laura J Van 't Veer
Journal:  Breast Cancer Res Treat       Date:  2007-03-28       Impact factor: 4.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.